Uncover what still blocks better desmoid care—predicting progression, treating FAP cases, and protecting fertility as new oral therapies emerge.
Nam Bui, MD
Advertisement
Articles by Nam Bui, MD
Experts explain modern desmoid tumor care: earlier systemic therapy, less surgery, and when ablation or radiation fits patients’ goals and risks.
Experts explain desmoid tumor workup, when to watch and when to treat, plus new local options and genetic screening essentials.
Drs Bui and Kelly discuss key long-term findings from the AMPECT trial investigating nab-sirolimus in patients with advanced malignant PEComa.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
June’s GI Rewind: CRC, Gastric Cancer See Several “Firsts” With FDA Review of Adjuvant IO, Global Approval of BRAF-Targeted and CAR T-Cell Therapies
2
Namodenoson Meets Safety End Point in PDAC, Shows Durable Survival Outcomes Pretreated Subgroup
3
SERENA-6 Controversies Push the Breast Cancer Field to Consider the Future Role of ctDNA-Guided Treatment Decisions
4
Taking Science from Bench to Bedside to the Block – Introducing Dr. Robert A. Winn
5